Risk of bladder tumours after childhood cancer: The British Childhood Cancer Survivor Study

BJU International

Volumn 106, Issue 7, 2010, Pages 1060-1069

  Frobisher, Clare ^a   Gurung, Pratik M S ^b   Leiper, Alison ^c   Reulen, Raoul C ^a   Winter, David L ^a   Taylor, Aliki J ^a   Lancashire, Emma R ^a   Woodhouse, Christopher R J ^b   Hawkins, Michael M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

bladder tumours; childhood cancer; second tumours; survivorship

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINOBLASTOMA; SEX DIFFERENCE; UNITED KINGDOM; EPIDEMIOLOGY; INFANT; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PRESCHOOL CHILD; REGISTER; STATISTICS AND NUMERICAL DATA; SURVIVOR; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; GREAT BRITAIN; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; REGISTRIES; SURVIVORS; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 77956629378     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09224.x     Document Type: Article

References (43)

1. Stiller C ed. Childhood Cancer in Britain: Incidence, Survival and Mortality. New York : Oxford University Press, 2007
2. Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2002 2 : 124 131
3. Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MCG. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 2004 91 : 1905 1910
4. Cancer Research UK. Cancer Statistics. Key Facts: Bladder Cancer. Available at: http://info.cancerresearchuk.org/cancerstats/types/bladder. Accessed 28 April 2009
5. Puente D, Hartge P, Greiser E et al. A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women. Cancer Cause Control 2006 17 : 71 9
6. Kaldor JM, Day NE, Kittelmann B et al. Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int J Cancer 1995 63 : 1 6
7. Travis LB, Curtis RE, Glimelius B et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995 87 : 524 530
8. Garcia-Closas M, Malats N, Silverman D et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysis. Lancet 2005 366 : 649 659
9. Cancer Research UK. UK cancer incidence statistics for males. Available at: http://info.cancerresearchuk.org/cancerstats/incidence/males/?a=5441. Accessed 28 April 2009
10. Cancer Research UK. UK cancer incidence statistics for females. Available at: http://info.cancerresearchuk.org/cancerstats/incidence/females/?a=5441. Accessed 28 April 2009
11. Office for National Statistics. Cancer statistics registrations. Registrations of cancer diagnosed in 2005, England. Series MB1. No. 36; 2008
12. Vincent TJ, Bayne AM, Brownbill PA, Stiller CA. Methods. In Stiller C ed. Childhood Cancer in Britain: Incidence, Survival and Mortality, New York : Oxford University Press, 2007 : 7 21
13. Hawkins MM, Lancashire ER, Winter DL et al. The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer 2008 50 : 1018 1025
14. Cooper N, Cartwright R. Bladder. In Quinn M, Wood H, Cooper N, Rowan S eds. Cancer Atlas of the United Kingdom and Ireland 1991-2000, Basingstoke : Palgrave Macmillan, 2005 : 39 50
15. Shah A, Rachet B, Mitry E, Cooper N, Brown CM, Coleman MP. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer 2008 99 : S86 9
16. Office of National Statistics. Cancer incidence rates. Available at: http://www.statistics.gov.uk. Accessed 15 January 2009
17. Pintilie M. Competing Risks. A Practical Perspective. New York : John Wiley & Sons, 2006
18. Coviello V, Bogges M. Cumulative incidence estimation in the presence of competing risks. Stata J 2004 4 : 103 112
19. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 2007 121 : 2233 2240
20. Olsen JH, Moller T, Anderson H et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 2009 101 : 806 813
21. Bassal M, Mertens AC, Taylor L et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006 24 : 476 483
22. Metayer C, Lynch CF, Clarke EA et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000 18 : 2435 2443
23. Bluhm EC, Ronckers C, Hayashi RJ et al. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 2008 111 : 4014 4021
24. Maule M, Scelo G, Pastore G et al. Risk of second malignant neoplasms after childhood leukaemia and lymphoma: an international study. J Natl Cancer Inst 2007 99 : 790 800
25. Kleinerman RA, Tucker MA, Tarone RE et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 2005 23 : 2272 2279
26. Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, Van Leeuwen FE. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 2008 100 : 1771 1779
27. Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004 96 : 357 363
28. Yandell DW, Poremba C. Genetics of retinoblastoma: implications for other human cancers. Med Pediatr Oncol Suppl 1996 1 (Suppl. 1 25 8
29. Mitra AP, Birkhahn M, Cote RJ. p53 and retinoblastoma pathways in bladder cancer. World J Urol 2007 25 : 563 571
30. Brewster SF, Knowles M, Poller D, Gingell JC. Inactivation of the retinoblastoma susceptibility gene in metachronous eye and bladder tumours. Br J Urol 1998 81 : 494 495
31. Morris SD, Onadim Z, Yu RO. A case of naevus sebaceous associated with familial retinoblastoma, multiple lipomata and meningioma. Br J Dermatol 2000 143 : 211 214
32. Wong FL, Boice JD Jr. , Abramson DH et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997 278 : 1262 1267
33. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J. Neurofibromatosis type 1 and childhood cancer. Cancer 1993 72 : 2746 2754
34. Kony SJ, de Vathaire F, Chompret A et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997 350 : 91 5
35. Meadows AT, Baum E, Fossati-Bellani F et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985 3 : 532 8
36. Meadows AT. Second tumours. Eur J Cancer 2001 37 : 2074 2081
37. Agarwala S, Hemal AK, Seth A, Gupta AK, Bhatnagar V, Mitra DK. Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood. Eur J Pediatr Surg 2001 11 : 207 210
38. Kawamura J, Sakurai M, Tsukamoto K, Tochigi H. Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma. Urol Int 1993 51 : 49 53
39. Kersun LS, Wimmer RS, Hoot AC, Meadows AT. Secondary malignant neoplasms of the bladder after cyclophosphamide treatment for childhood acute lymphocytic leukaemia. Pediatr Blood Cancer 2004 42 : 289 291
40. Fairchild WV, Spence CR, Solomon HD, Gangai MP. The incidence of bladder cancer after cyclophosphamide therapy. J Urol 1979 122 : 163 164
41. International Agency for Research on Cancer (IARC) and World Health Organisation (WHO). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 83. Tobacco Smoke and Involuntary Smoking. Summary of Data Reported and Evaluation. Lyon : IARC, 2004
42. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, Version 3.0. 2008. Available at: http://www.survivorshipguidelines.org. Accessed 6 March 2009
43. United Kingdom Children's Cancer Study Group and Late Effects Group. Therapy-based long-term follow-up practice statement. Available at: http://www.cclg.org.uk/public/followup/PracticeStatement/index.html. Accessed 4 June 2007